Clozapine responsive catatonia: A series of five cases

Chattopadhyay, Somsubhra; Saha, Indranil; Dan, Amitava; Bhattacharyya, Kaberi

doi:10.4103/0972-6748.110955

Cited by 23 publications

(8 citation statements)

References 15 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Valevski et al [ 11 ] described two patients who responded well to risperidone. There are multiple positive reports on the treatment of catatonia with clozapine, but due to the slow introduction and close monitoring required with clozapine this may only be an option limited to chronic, severe, and treatment-resistant cases [ 12 – 14 ].…”

Section: Discussionmentioning

confidence: 99%

Acute catatonia on medical wards: a case series

Doran

Sheehan

2018

J Med Case Reports

View full text Add to dashboard Cite

BackgroundCatatonia is a behavioral syndrome which presents with an inability to move normally. It is associated with mood disorders and schizophrenia, as well as with medical and neurological conditions. It is an expression of the severity of the underlying condition.The awareness of catatonia among general medical doctors and even psychiatrists is poor. It is often seen as an historical diagnosis. Because of this, catatonia is often not recognized. If patients in catatonic states are not diagnosed, their condition is likely to progress with a risk of increased morbidity and potentially fatal outcomes.Case presentationWe present a case series of three acutely unwell, frail, elderly medical patients (a 65-year-old Irish woman, a 75-year-old Irish woman, and a 68-year-old Irish woman) with a background of longstanding well-controlled psychiatric illnesses, who developed acute catatonia while being treated for medical conditions in a general medical in-patient setting.ConclusionsCatatonia is common in acute medical settings but is underdiagnosed due to the low awareness of the condition among both general medical doctors and psychiatrists. Within a short time period, we diagnosed and successfully treated three acutely unwell patients in acute medical settings. We would like to increase the awareness of catatonia among medical doctors.

show abstract

Section: Discussionmentioning

confidence: 99%

Acute catatonia on medical wards: a case series

Doran

Sheehan

2018

J Med Case Reports

View full text Add to dashboard Cite

show abstract

“…Coming to the management, Clozapine is recommended for management of TD [2]. Literature also supports efficacy of Clozapine in catatonia [4,8]. The stronger D1 binding and rapid dissociation from D2 receptors can explain its efficacy in both the disorders [2].…”

Section: Discussionmentioning

confidence: 99%

A case report of Olanzapine induced Tardive Dystonia presenting along with Catatonia

Singh¹,

Khess²,

Simlai³

et al. 2015

J Clin Toxicol

View full text Add to dashboard Cite

show abstract

“…[10][11][12] In line with the usual recommendation for clozapine initiation, the treatment requires a baseline evaluation, slow titration and close monitoring. 10 A daily dose between 300 and 750 mg may be required to achieve efficacy, 10,11 and relief from catatonic symptoms is observed within 2-7 weeks of treatment. [10][11][12] The neurobiology of catatonia is complex, [13][14][15] and clozapine may be effective through its actions at various biological junctures of this neurobiology.…”

mentioning

confidence: 99%

“…3,4 Even though NMS was described in some catatonic patients treated with clozapine, 8 this medication has been shown to be more efficient than other APs for the treatment of chronic catatonia with schizophrenia, although most of the studies reported on a small number of cases. [10][11][12] In line with the usual recommendation for clozapine initiation, the treatment requires a baseline evaluation, slow titration and close monitoring.10 A daily dose between 300 and 750 mg may be required to achieve efficacy, 10,11 and relief from catatonic symptoms is observed within 2-7 weeks of treatment. …”

mentioning

confidence: 99%

“…10 A daily dose between 300 and 750 mg may be required to achieve efficacy, 10,11 and relief from catatonic symptoms is observed within 2-7 weeks of treatment. [10][11][12] The neurobiology of catatonia is complex, [13][14][15] and clozapine may be effective through its actions at various biological junctures of this neurobiology. 10,16 It is possible that the net effect of clozapine on dopamine neurotransmission (low D2 receptor occupancy coupled with increased dopamine release in the striatum via the stimulation of 5-HT 1A receptors) contributes to the anticatatonic effects of clozapine.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Clozapine for the management of persistent catatonia

Tabbane¹,

Halayem²,

Joober³

2016

jpn

View full text Add to dashboard Cite

A 42-year-old man with a diagnosis of undifferentiated schizophrenia has been hospitalized several times since age 23 for psychotic relapses, usually in the context of nonadherence to medication.During the last relapse, he was concerned about many plots being planned against him for vague reasons. He experienced catatonic symptoms, including rigid postures, resistance to eating and drinking, immobility, mutism and staring, and displayed periods of unexplained aggressiveness. Physical examination revealed waxy flexibility with no extrapyramidal symptoms or fever. He had a score of 24 on the Bush-Francis Catatonia Rating Scale (BFCRS), which is compatible with a severe form of catatonia.Even in a patient with psychiatric illness, a plethora of medical conditions can be associated with catatonia. This emphasizes the importance of ruling out a somatic cause.1,2 The patient was assessed by an internist and a neurologist, and no clinical abnormalities were identified. Laboratory results, including MRIs and electroencephalography (EEG) scans were unremarkable.Because the patient refused intravenous injections, lorazepam was initiated orally and was rapidly titrated up to 6 mg daily for more than 15 days, without any effect. However, higher doses were not tolerated. Subsequently, the patient accepted intramuscular injections, which resulted in partial and transitory remission of the catatonic symptoms for a few hours. After a gradual discontinuation of benzodiazepines (BZD), electroconvulsive therapy (ECT) was initiated. Two series of treatments of 20 sessions each with unitemporal followed by bitemporal electrode placement were completed with no significant improvement, and the score on the BFCRS remained between 20 and 24.Risperidone (4-6mg/d) and aripiprazole (20mg/d) were each used for a period of at least 6 weeks but were not able to alleviate catatonia symptoms. Parkinsonism was systematically assessed and corrected using anticholinergic agents as needed. Finally clozapine was initiated and gradually titrated to 400 mg over a period of 5 weeks. A significant decrease in the BFCRS score (final score of 4) was observed after 5 weeks, allowing for long-deferred care and discharge from the hospital.In contrast to acute catatonia, chronic catatonia is less responsive to first-line treatments, including lorazepam and ECT, especially in the context of schizophrenia.2-7 Using lorazepam for longterm periods has been proposed as a therapeutic option, although the therapeutic response may be slower, taking months rather than days. 2,4 It is generally recommended to discontinue antipsychotics (APs) in patients presenting with catatonia, as APs increase parkinsonism, leading to a potential aggravation of catatonia and an increase in the risk of neuroleptic malignant syndrome (NMS). 2,4,8However, atypical APs are known to have weak γ-aminobutyric acid (GABA) agonist activity and serotonin (5-HT 2 ) antagonism that could stimulate dopamine release in the prefrontal cortex and alleviate catatonic symptoms. 9 In the event that the...

show abstract

Clozapine responsive catatonia: A series of five cases

Cited by 23 publications

References 15 publications

Acute catatonia on medical wards: a case series

Acute catatonia on medical wards: a case series

A case report of Olanzapine induced Tardive Dystonia presenting along with Catatonia

Clozapine for the management of persistent catatonia

Contact Info

Product

Resources

About